CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-10 | Parsey Merdad Chief Medical Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +89,660 | 89,660 | ||
| 2024-03-10 | Parsey Merdad Chief Medical Officer | Grant or award · Restricted Stock Unit | +17,640 | 48,214 | ||
| 2024-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +10,800 | 479,489 | ||
| 2024-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise | +19,140 | 498,629 | ||
| 2024-03-10 | O'Day Daniel Patrick Chairman & CEO | Shares withheld for taxes | −13,782 | $75.12 | $1.0M | 484,847 |
| 2024-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −10,800 | 100,092 | ||
| 2024-03-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −19,140 | 80,952 | ||
| 2024-03-10 | O'Day Daniel Patrick Chairman & CEO | Grant or award · Non-qualified Stock Option (Right to Buy) | +279,130 | 279,130 | ||
| 2024-03-10 | O'Day Daniel Patrick Chairman & CEO | Grant or award · Restricted Stock Unit | +54,910 | 135,862 | ||
| 2024-03-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +3,025 | 116,172 | ||
| 2024-03-10 | Mercier Johanna Chief Commercial Officer | Option exercise | +6,819 | 122,991 | ||
| 2024-03-10 | Mercier Johanna Chief Commercial Officer | Shares withheld for taxes | −4,559 | $75.12 | $342K | 118,432 |
| 2024-03-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −3,025 | 36,962 | ||
| 2024-03-10 | Mercier Johanna Chief Commercial Officer | Option exercise · Restricted Stock Unit | −6,819 | 30,143 | ||
| 2024-03-10 | Mercier Johanna Chief Commercial Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +87,970 | 87,970 | ||
| 2024-03-10 | Mercier Johanna Chief Commercial Officer | Grant or award · Restricted Stock Unit | +17,305 | 47,448 | ||
| 2024-03-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +3,025 | 132,781 | ||
| 2024-03-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +6,707 | 139,488 | ||
| 2024-03-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −4,505 | $75.12 | $338K | 134,983 |
| 2024-03-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,025 | 35,040 |
Page 29 of 30 · 590 trades